Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MPO | P05164 | 4/20 | 0.61 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.61 |
| ▸ | SCN8A | Q9UQD0 | 1/20 | 0.59 |
| ▸ | ACHE | P22303 | 4/20 | 0.52 |
| ▸ | MEN1 | O00255 | 1/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.50 |
| ▸ | HPGD | P15428 | 1/20 | 0.49 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.49 |
| ▸ | CA2 | P00918 | 3/20 | 0.47 |
| ▸ | CA12 | O43570 | 2/20 | 0.47 |
| ▸ | CA9 | Q16790 | 2/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.47 |
| ▸ | TSHR | P16473 | 1/20 | 0.47 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.47 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.47 |
| ▸ | CA1 | P00915 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20354426 | 0.93 | MEN1 (0.59) | MPOSLC6A4SCN8AACHEMEN1 | |
| SCHEMBL21674321 | 0.89 | MPO (0.59) | MPOSLC6A4SCN8AACHEMEN1 | |
| SCHEMBL14399068 | 0.83 | MPO (0.63) | MPOSLC6A4SCN8AACHEHPGD | |
| SCHEMBL7245746 | 0.82 | MPO (0.62) | MPOSLC6A4SCN8AACHEHPGD | |
| Formic Acid SCHEMBL6319998 | 0.81 | MPO (0.55) | MPOSLC6A4SCN8AACHEMEN1 | |
| SCHEMBL631227 | 0.80 | MPO (0.58) | MPOSLC6A4SCN8AMEN1KMT2A | |
| SCHEMBL6071681 | 0.80 | MPO (0.60) | MPOSLC6A4SCN8AMEN1KMT2A | |
| SCHEMBL9784389 | 0.79 | CHRM2 (0.72) | MEN1KMT2ASMN1; SMN2HPGDCHRM2 | |
| SCHEMBL5013296 | 0.79 | CHRM2 (0.76) | SCN8AACHECHRM2CA2CA12 | |
| SCHEMBL13975424 | 0.79 | ACHE (0.52) | MPOSLC6A4ACHEMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120295903-A1 | FLAVIN DERIVATIVES | BLOUNT KENNETH F (US) | 2012-11-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120295903-A1 | FLAVIN DERIVATIVES | BLVRB, FLAD1, FDPS | MPO 1664/4885SLC6A4 1439/4885SCN8A 4528/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.